Your browser doesn't support javascript.
loading
A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT).
Koh, Kwang Kon; Nam, Chang Wook; Chao, Ting-Hsing; Liu, Ming-En; Wu, Chiung-Jen; Kim, Dong-Soo; Kim, Chong-Jin; Li, Ivy; Li, Jianyong; Baccara-Dinet, Marie T; Hsiao, Pi-Jung; Chiang, Chern-En.
Afiliação
  • Koh KK; Gachon University Gil Medical Center, Incheon, Korea.
  • Nam CW; Keimyung University Dongsan Medical Center, Daegu, South Korea.
  • Chao TH; Department of Internal Medicine, College of Medicine and Hospital, National Cheng Kung University, Tainan City, Taiwan.
  • Liu ME; Division of Cardiology, Department of Internal Medicine, Hsinchu Mackay Memorial Hospital, Hsinchu, Taiwan.
  • Wu CJ; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Tao-Yuan City, Taiwan.
  • Kim DS; Inje University Busan Paik Hospital, Busan, Korea.
  • Kim CJ; Kyung Hee University Hospital at Gangdong, Seoul, Korea.
  • Li I; Sanofi R&D, Beijing, China.
  • Li J; Sanofi R&D, Shanghai, China.
  • Baccara-Dinet MT; Sanofi R&D, Montpellier, France.
  • Hsiao PJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Electronic address: pjhsiao@cc.kmu.edu.tw.
  • Chiang CE; General Clinical Research Center, Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan.
J Clin Lipidol ; 12(1): 162-172.e6, 2018.
Article em En | MEDLINE | ID: mdl-29153823

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipercolesterolemia / Anticorpos Monoclonais Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipercolesterolemia / Anticorpos Monoclonais Idioma: En Ano de publicação: 2018 Tipo de documento: Article